cSw student writers are required to identify and interview at least one researcher at the peer-reviewed publication level and are encouraged to identify and interview other bona fide content experts. Writers consult with their communications mentors regarding the selection and recruitment of content experts.
Content experts, broadly speaking, are highly credible individuals having demonstrated expertise in specific areas. In the cSw context, content experts have knowledge directly related to the topic a given cSw writer chooses and include, but aren’t necessarily limited to:
- Authors of peer-reviewed publications
- Interpreters of scientific and technologic concepts and/or data
- Researchers, bloggers, and officials, editors or writers associated with high quality science- and technology-related institutions, organizations, publications, or credible mass media that cover science
- KOLs (key opinion leaders)
- Inventors, developers, and commercializers of discoveries and advances in science and/or technology
- Investors in science- and technology-related endeavors
- Consumers (e.g., patients, physicians and other medical industry personnel)
- Members of advocacy groups
2019/2020 Content Experts
Michael Goldstein, Ph.D.
Dr. Michael Goldstein is an Associate Professor of Cornell University and Director of the Behavioral Analysis of Beginning Years (B.A.B.Y.) Laboratory. He received his Ph.D. in Developmental Psychology and Animal Behavior in 2001 from Indiana University. Since then, he’s been working with infants to better understand their vocal learning processes. In 2008, he won the Distinguished Early Career Contribution Award from the International Society on Infant Studies. Learn more about Dr. Goldstein and his research here.
Simon E. Fisher, Ph.D.
Dr. Simon E. Fisher is the Director of the Max Planck Institute for Psycholinguistics. He’s also a Professor of Language and Genetics at the Donders Institute for Brain, Cognition and Behaviour in Nijmegen, the Netherlands. His research focuses mainly on genetic processes within the brain and the role of FOXP2 in language development. He was awarded the Eric Kandel Young Neuroscientists Prize in 2009. Learn more about Dr. Fisher and his research here.
Tom Anchordoquy, Ph.D.
Dr. Tom Anchordoquy is a professor at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of Colorado. He received his Ph.D. in zoology at the University of California at Davis. His lab focuses on the development of synthetic delivery systems and use of exosomes for drug delivery. Read more about Dr. Anchordoquy and his research here.
Rose Doerfler is the lead Ph.D. student on a project led by Dr. Kathryn Whitehead, Associate Professor of Chemical Engineering and Biomedical Engineering at Carnegie Mellon University. Read more about research in the Whitehead Lab here.
2018/2019 Content Experts
Dr. Harri Hemilä
As an epidemiologist, public health specialist, and biochemist, Dr. Harri Hemilä is a researcher for the University of Helsinki, Finland, who studies the effects of zinc acetate and vitamin C on the common cold. He received both his MD and two PhDs at the University of Helsinki. His meta-analysis of common cold patients has successfully quantified the effectiveness of zinc acetate lozenges on human health.
Dr. Ananda S. Prasad
Dr. Ananda S. Prasad has studied the effects of trace elements on human metabolism for over 50 years, making important contributions towards the field of public health. He published several studies on zinc throughout the 1960s, and in 1974 both the Congress and the National Academy of Science declared zinc as an essential element for humans. Now as the director of the Division of Hematology at Wayne State University, Dr. Prasad has published over 300 studies and fifteen books. He is the founder of two scientific journals and is the recipient of numerous distinctions and awards within his field.
Dr. Tao Che
Dr. Tao Che is a postdoctoral research assistant at the University of North Carolina at Chapel Hill. After receiving his Ph.D. at Case Western Reserve University, he has focused on researching the structure and function of the kappa opioid receptor.
Dr. Christopher Stein
Dr. Christoph Stein is a professor and the medical director of the Department of Anesthesiology and Operative Intensive Care Medicine at Charité in Berlin. He is internationally recognized in the field of opioid pharmacology, molecular mechanisms, and pain treatment.
Dr. Ronald N. Miles
Dr. Ronald N. Miles received his Ph.D. in Mechanical Engineering from the University of Washington. As a lecturer at UC Berkeley, Professor at the State University of New York Binghamton, and Associate Dean for Research at Binghamton University, he has received numerous acclamations for his teaching and research. Presently, his research seeks to develop sound sensors inspired by nature. In his free time, he visits his farm, in the warm company of goats, horses, chickens, and birds.
Kimberly Skinner, after 18 years as a passionate clinical audiologist, is currently a Ph.D. candidate in speech and hearing sciences at Indiana University. She works in the University’s Auditory Perception Lab where she researches speech perception, aging, and tinnitus. When away from her research, she enjoys spending time with her daughter.
Dr. Lung-Chi Chen
Dr. Lung-Chi Chen is a professor in the Department of Environmental Medicine at New York University (NYU). Since receiving his Ph.D. from NYU, Chen has authored over 120 research papers in the past four decades. He is internationally recognized as an inhalation toxicology expert and his research seeks to understand the effects of environmental toxicants on people’s health.
Dr. Alfredo Morabia
Dr. Morabia is a professor in the Department of Epidemiology at the Mailman School of Public Health at Columbia University, and at the Barry Commoner Center for Health and the Environment at Queens College, CUNY. The author of numerous books, his scientific research primarily involves urban health and history.
Dr. Christoph Meinert
Dr. Christoph Meinert is a Postdoctoral Research Associate at the Queensland University of Technology, Australia. He studied both biotechnology and regenerative medicine, which he now uses to help develop the fields of 3D-printed microfibers and Melt Electrospinning Writing. Dr. Meinert has collaborated on and authored many papers on tissue engineering, and over the years has won awards and recognition for his research.
Dr. Onur Bas
Dr. Onur Bas is a Postdoctoral Research Associate at the Centre in Regenerative Medicine, Institute of Health and Biomedical Innovation, Queensland University of Technology, Australia. He has authored papers ranging from finding functional and soft biomaterials, engineering biologically functional tissues, and further developing Melt Electrospinning Writing. His current research project is composed of finding soft network composites (fiber reinforced hydrogels) for soft tissue engineering applications.
Dr. Bryce Mander
Dr. Bryce Mander is currently an assistant professor in the Psychiatry & Human Behavior School of Medicine at the University of California, Irvine. After earning his Ph.D. in Neuroscience at Northwestern University, Dr. Mander completed his postdoctoral fellowship in the Department of Psychology at the University of California, Berkeley. Currently, his interest lies in understanding the role of sleep in cognitive functions and the health of the brain. One of his major works proved that brain activity during deep sleep has a direct correlation with loss of memory and was a breakthrough. It was published in Neuron, a highly influential and reliable journal in the field of neuroscience.
Dr. Rowen Zetterman
Dr. Rowen Zetterman is a professor of internal medicine at the University of Nebraska Medical Center. In addition to this, he is an internist, gastroenterologist, and hepatologist. Dr. Zetterman’s research interests include work in the pathogenesis of alcoholic liver disease and treatment of liver disease. His hobbies include travel, fishing, and spending time with his seven grandchildren.
Dr. Patricia Carrieri
Dr. Patrizia Carrieri is a research professor at the French National Institute of Health and Medical Research (INSERM) – University Aix-Marseille in the field of epidemiology and public health. Her work primarily focuses on the impact of psychoactive substances, or drugs that affect the mind (tobacco, alcohol, cannabis, and coffee), and she works to improve the lifestyles and clinical outcomes of people living with HIV and Hepatitis C. Her research in addiction helped change the 2016 French Health law which now promotes novel Hepatitis C preventive interventions.
Dr. Maya Koronyo-Hamaoui
Dr. Maya Koronyo-Hamaoui is an associate professor in neurosurgery and biomedical sciences and head of the Alzheimer’s disease research laboratory at Cedars-Sinai. Her work focuses on Alzheimer’s disease and includes diagnostic biomarkers, monitoring biomarkers, and therapy approaches in addition to studying the retina and developing the retinal scan. She is currently working on linking the amyloid-beta protein to retinal abnormalities and visual problems.
Dr. Alexander Mankin
Dr. Alexander Mankin is a professor and director at the Center for Pharmaceutical Biotechnology at the University of Illinois at Chicago College of Pharmacy. He obtained his Ph.D. from Moscow University. His lab focuses on studying the ribosome and new classes of antibiotics.
Dr. Anna Maria Aloisi
Dr. Anna Maria Aloisi is an associate professor and Director of the Department of Physiology at the University of Siena in Italy. As a founder of the European Pain School and member of the International Association for the Study of Pain, she is highly involved in pain-related studies. Her works have been in over 200 publications. One of her most prominent studies is sex differences in pain and analgesia, specifically how different hormones produced in men and women affect sensitivity to pain and analgesia.
Dr. Donna Krasnewich
Dr. Donna Krasnewich is a clinical geneticist and practicing pediatrician. She got her medical degree from Wayne State University School of Medicine and now works in Kensington, Maryland. Dr. Krasnewich is also part of the National Institutes of Health, where she is responsible for managing research grants involving genetics.
Dr. Manel Esteller
Dr. Manel Esteller is the director of the Cancer Epigenetics and Biology Program at the Bellvitge Biomedical Research Institute in Catalonia, Spain. He received his undergraduate degree in Medicine then his doctorate in Molecular Genetics of Endometrial Carcinoma from the University of Barcelona in 1996 where he is now a professor. His research interests include the molecular genetics of hereditary breast cancer and DNA methylation and its relationship with cancer in humans. His research helped establish that the hypermethylation of tumor suppressor genes is a characteristic trait of cancer tumors. In addition to his research, he serves as the editor-in-chief of the peer-reviewed journal Epigenetics.
Dr. Karl T. Kelsey
Dr. Karl T. Kelsey is a Professor Epidemiology & Pathology and Laboratory Medicine at Brown University. He received his undergraduate and doctoral degrees from the University of Minnesota and later his Masters of Occupational Health from Harvard University in 1984 where he would teach at Harvard’s School of Public Health (now T. H. Chan). His research interests include biomarkers in environmental disease, chronic disease epidemiology, and tumor biology with the goal of understanding individual susceptibility to certain cancers. His work uses an epidemiologic approach to characterize genetic alterations of genes in the causal pathway for malignant tumors. Currently, he serves as an Ad Hoc Advisor for the Massachusetts Department of Environmental Protection, a reviewer for the Cancer Research Campaign in the UK, and is on the editorial board for three peer-reviewed journals.
Steven Bosinger, Ph.D
Steven Bosinger, Ph.D., is a researcher within the Yerkes National Primate Research Center’s Division of Microbiology & Immunology and an Assistant Professor in the Emory School of Medicine Department of Pathology & Lab Medicine. He is also Director of the Yerkes Research Center’s Nonhuman Primate Genomics Core, which since 2012 has been a resource to researchers who are interested in applying genomic technology to the study of primates and the immune system.
Peter Ma is the co-founder of Doctor Hazel and graduated from N.J.I.T. with a B.S. in computer engineering. Mike Borozdin is also the co-founder of Doctor Hazel and VP of Engineering at the mortgage software company, Ethos Lending. The engineers created Doctor Hazel at one of the numerous hackathons that they attended. After a mutual friend’s death from cancer, they decided to apply their AI knowledge to create software to screen for lesions. Since then, both have been featured in several expositions (Techcrunch, Intel AI Academy, Mobi Health News) and have demonstrated the abilities of their software at several conferences.
Daniel Rubin is a professor at Stanford University who currently teaches biomedical informatics as well as biomedical data science. His main focus is imaging informatics which investigates how computers can help physicians analyze images. He is a graduate of Stanford University School of Medicine and a board-certified radiologist.
Dr. Gitte J. M. Christensen
Dr. Gitte J. M. Christensen is currently a research scientist and product developer at DermaPharm A/S located in Faarup, Denmark. She received her Masters degree in science in 2011 and her PhD in 2015 at Aarhus University in Aarhus, Denmark. She has published several microbiology and dermatology papers, with her most recent one being published by The Danish Environmental Protection Agency, called Less preservatives in cosmetics – MiKoKo.
Dr. Harold Bernhardt
Dr. Harold Bernhardt is a research fellow in the Department of Anatomy and Department of Biochemistry at the University of Otago in Dunedin, New Zealand. Although he is interested in a range of things, his research focuses on the evolution of tRNA (transfer RNA) and the origin of life, particularly concerning the RNA world hypothesis. Dr. Bernhardt was awarded a grant from the Marsden Fund in 2013 to investigate the prebiotic chemical evolution of RNA.
Dr. Charles Carter, Jr.
Dr. Charles Carter, Jr. is a professor of biochemistry and biophysics at the University of North Carolina at Chapel Hill. He obtained his Ph.D. at the University of California, San Diego in 1972, and since then he has been studying the origins of enzyme catalysis. Dr. Carter’s research challenges the RNA world hypothesis and offers additional insight into the origin of life.
2017/18 Content Experts
Dr. Joseph Vinetz
Dr. Joseph Vinetz is an infectious disease specialist based in La Jolla, California. He graduated from Yale University in 1991 and completed his training in internal medicine at Johns Hopkins University. He has been studying the malaria parasite for over 28 years and has been working on a candidate vaccine for malaria for over twenty years. His accomplishments aren’t limited to advancements in understanding in malaria as he has also been researching other tropical diseases like leptospirosis and brucellosis. In addition, Dr. Vinetz is a talented clarinetist.
Dr. Emily Goldberg
Dr. Emily Goldberg is a postdoctoral fellow at Yale University. She obtained her Ph.D. in the Nikolich-Zugich lab at the University of Arizona. Dr. Goldberg works in the field of immunology. More specifically, her research is focused on aging and metabolism. She started volunteering in labs in high school and kept researching as an undergrad and in grad school. Describing her experiences, she said “I got lucky,” with a laugh, before going on to detail one of the projects she worked on which sparked her interest in her current topic. When she isn’t in the lab, Dr. Goldberg might be found doing pottery or playing ultimate frisbee.
Dr. Briony Forbes
Dr. Briony Forbes received her Ph.D. from the University of Adelaide in biochemistry. She has held postdoctoral positions at the University of Adelaide, Discipline of Biochemistry and at CSIRO Division of Human Nutrition. She is interested in science that can change society and have positive impacts on the lives of others. She is passionate about the science of metabolism, insulin, and diabetes, as well as the biochemistry of cell signaling in cancer.
Dr. Henry Daniell
Dr. Henry Daniell is a professor and Interim Chair of the Department of Biochemistry at the University of Pennsylvania. To improve on the current production of vaccines and biopharmaceuticals, he pioneered and advanced the concept of expressing foreign genes in chloroplast DNA. These therapeutic proteins produced are used in treatments for diseases such as hemophilia and diabetes, as well as oral vaccines for infectious diseases such as polio, tuberculosis, and others, as well as tolerance for autoimmune disorders. His works have been featured in over 200 publications, and received numerous awards, patents, and grants.
Dr. Sujan Shresta
Dr. Sujan Shresta is an Associate Professor in the Division of Inflammation Biology at the La Jolla Institute for Allergy and Immunology. Dr. Shresta studies the immunology and virology of the Dengue and Zika virus and their connection to viral immunopathogenesis.
John Aitken is a microbiologist based in New Zealand. He became interested in Crohn’s after a scare with Crohn’s-like symptoms at the age of 23. As the Board Director of Otakaro Pathways, a research organization in New Zealand, Aitken developed a test to identify MAP in patients’ blood and has since been a crucial advocate for MAP research. He is driven by what he calls “Crohn’s mothers” — the distressed parents of kids who have Crohn’s.
Dr. Rodrick Chiodini
Dr. Rodrick Chiodini pioneered research into the association between Crohn’s and MAP in the 1980s as a researcher at the University of Connecticut and has been a key player in Crohn’s research and advocacy ever since. MAP research likely wouldn’t exist if not for Rod’s dedication.
Dr. Gwenaelle Géléoc
Dr. Gwenaelle Géléoc is a Research Associate in Otolaryngology and Neurobiology at Boston Children’s Hospital and Assistant Professor of Otolaryngology at Harvard Medical School. As a principal investigator of the Holt/Géléoc Lab, which she runs with her husband, she conducts research involving the structure and function of sensory hair cells in the inner ear. When she is not busy working in the lab or writing articles, Dr. Géléoc enjoys running and spending time with her two children.
Dr. Jae Park
Dr. Jae Park is a hematologist-oncologist at Memorial Sloan Kettering Cancer Center in New York City. He loves his work on the biology of blood cancers and enjoys talking with patients and helping them get better. He became interested in CAR T-cell therapy during his oncology fellowship when he saw the huge potential of this approach in battling cancer.
Dr. Robert Krikorian
Dr. Robert Krikorian is a Professor in the Department of Psychiatry & Behavioral Neuroscience and Director of the Cognitive Aging Program at the University of Cincinnati Academic Health Center. Interested by the relationships in the brain, Krikorian was curious as to if blueberries could improve cognitive functions in humans. Through his studies, he has conducted clinical research involving the effects of blueberries on cognitive performance, hoping to discover preventive measures to decrease the risk of Alzheimer’s. When he’s not busy in the lab, Dr. Krikorian enjoys traveling to the southwest, driving sports cars, and playing/watching baseball.
Dr. Lisa Abegglen
Dr. Lisa Abegglen is an Instructor at the University of Utah (Department of Pediatrics). She works closely with Dr. Joshua Schiffman and their team of scientists. Her work focuses on genetic cancer predisposition syndromes and comparative oncology. Currently, she is researching molecular mechanisms of cancer resistance in elephants to hopefully apply it to improve human health in the future. Her past experience as a drug discovery scientist in the industry will help with these efforts. She shares her passion for science with her children (4 and 6 years old), who enjoy visiting the lab.
Dr. Tim Bugg
Dr. Tim Bugg is a professor of Biological Chemistry at the University of Warwick in Coventry, England. He has studied enzymes involved in bacterial cell wall synthesis since his post-doctoral work at Harvard Medical School in 1989. He is excited to be part of a potential new breakthrough in treating antibiotic-resistant tuberculosis and hopes that it may save lives in the future.
Dr. Rosie Brown
Dr. Rosie Brown received her PhD in from the University of Otago in 2010 in the Department of Anatomy and the Department of Physiology. She is currently a Research Fellow at the University of Otago Medical School in Dunedin, New Zealand in the Department of Anatomy. Her research seeks to understand how a mother’s brain adapts during pregnancy through hormone signaling and other processes to facilitate a behavior change, allowing her to care for her young—an exciting area in the scientific community.